NO991011D0 - Fast skumpreparater med aktiv bestandel og fremgangsmÕte for fremstilling derav - Google Patents
Fast skumpreparater med aktiv bestandel og fremgangsmÕte for fremstilling deravInfo
- Publication number
- NO991011D0 NO991011D0 NO991011A NO991011A NO991011D0 NO 991011 D0 NO991011 D0 NO 991011D0 NO 991011 A NO991011 A NO 991011A NO 991011 A NO991011 A NO 991011A NO 991011 D0 NO991011 D0 NO 991011D0
- Authority
- NO
- Norway
- Prior art keywords
- active ingredient
- pct
- preparation
- solid foam
- foam preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/122—Hydrogen, oxygen, CO2, nitrogen or noble gases
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19635676A DE19635676A1 (de) | 1996-09-03 | 1996-09-03 | Feste geschäumte Wirkstoffzubereitungen |
PCT/EP1997/004550 WO1998009616A1 (de) | 1996-09-03 | 1997-08-21 | Feste geschäumte wirkstoffzubereitungen |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991011D0 true NO991011D0 (no) | 1999-03-02 |
NO991011L NO991011L (no) | 1999-03-03 |
Family
ID=7804471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991011A NO991011L (no) | 1996-09-03 | 1999-03-02 | Fast skumpreparater med aktiv bestandel og fremgangsmÕte for fremstilling derav |
Country Status (22)
Country | Link |
---|---|
US (1) | US6150424A (no) |
EP (1) | EP0932393B1 (no) |
JP (1) | JP2000517327A (no) |
CN (1) | CN1124129C (no) |
AT (1) | ATE215362T1 (no) |
AU (1) | AU740856B2 (no) |
BG (1) | BG103214A (no) |
BR (1) | BR9711982A (no) |
CA (1) | CA2264588C (no) |
CZ (1) | CZ67699A3 (no) |
DE (2) | DE19635676A1 (no) |
DK (1) | DK0932393T3 (no) |
ES (1) | ES2175469T3 (no) |
HR (1) | HRP970472A2 (no) |
HU (1) | HUP9904101A3 (no) |
IL (1) | IL128439A (no) |
NO (1) | NO991011L (no) |
PT (1) | PT932393E (no) |
RU (1) | RU2200004C2 (no) |
TR (1) | TR199900447T2 (no) |
WO (1) | WO1998009616A1 (no) |
ZA (1) | ZA977861B (no) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19733505A1 (de) | 1997-08-01 | 1999-02-04 | Knoll Ag | Schnell wirksames Analgeticum |
DE19900457A1 (de) * | 1999-01-08 | 2000-07-13 | Basf Ag | Verfahren zur Herstellung von festen Dosierungsformen |
US6733789B1 (en) | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
US20040185099A1 (en) * | 2000-01-20 | 2004-09-23 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
DE10032456A1 (de) * | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
US20030175337A1 (en) * | 2001-10-29 | 2003-09-18 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
US20030091633A1 (en) * | 2001-11-15 | 2003-05-15 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
US20030118652A1 (en) * | 2001-11-15 | 2003-06-26 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
CA2471948A1 (en) * | 2002-01-03 | 2003-07-17 | Smithkline Beecham Corporation | Novel pharmaceutical dosage forms and method for producing same |
DE10207394B4 (de) * | 2002-02-21 | 2007-03-29 | Lts Lohmann Therapie-Systeme Ag | Geschmacksmaskierte oblatenförmige Arzneizubereitung |
US20030235613A1 (en) * | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
DE10227607A1 (de) * | 2002-06-20 | 2004-01-08 | Boxler Gmbh & Co. Kg | Paneel-Verbindung |
ES2382332T3 (es) | 2003-02-06 | 2012-06-07 | Aduro Biotech | Listeria atenuada para entrar en células no fagocíticas, vacunas que comprenden esta listeria y métodos de uso de las mismas |
US7695725B2 (en) * | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
AU2004224425B2 (en) * | 2003-02-06 | 2010-06-24 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US20070098801A1 (en) * | 2003-09-10 | 2007-05-03 | Janssen Pharmaceutica N.V. | Particles shaped as platelets |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
FR2886938B1 (fr) * | 2005-06-10 | 2008-04-18 | Armines Ass Loi De 1901 | Procede d'extrusion permettant de fabriquer des dispersions solides de principes actifs pharmaceutiques dans une matrice polymere |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
CA2757979A1 (en) * | 2009-04-09 | 2010-10-14 | Alkermes Pharma Ireland Limited | Controlled-release clozapine compositions |
WO2011086047A1 (en) | 2010-01-13 | 2011-07-21 | Azur Pharma Limited | Method for titrating clozapine |
DK2552245T3 (en) | 2010-03-26 | 2019-01-07 | Philip Morris Products Sa | INHIBITION OF SENSORY IRRITATION UNDER CONSUMPTION OF NON-SMOKABLE TOBACCO PRODUCTS |
US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
WO2011144727A1 (de) * | 2010-05-21 | 2011-11-24 | Basf Se | ZUBEREITUNGEN BIOLOGISCH AKTIVER SUBSTANZEN MIT VERGRÖßERTER OBERFLÄCHE AUF BASIS VON AMPHIPHILEN COPOLYMEREN |
US8636929B2 (en) | 2010-05-21 | 2014-01-28 | Basf Se | Nanoporous foamed active compound-containing preparations based on pharmaceutically acceptable thermoplastically workable polymers |
EP2571930A1 (de) * | 2010-05-21 | 2013-03-27 | Basf Se | Nanoporöse geschäumte wirkstoffhaltige zubereitungen auf basis von pharmazeutisch akzeptablen thermoplastisch verarbeitbaren polymeren |
EP2571490A2 (en) * | 2010-05-21 | 2013-03-27 | President and Fellows of Harvard College | Foam or particles for applications such as drug delivery |
EP2463327A3 (de) * | 2010-12-10 | 2015-06-03 | Basf Se | Verfahren zur herstellung von granulaten, enthaltend mindestens eine wasserlösliche komponente |
WO2012125297A1 (en) | 2011-03-01 | 2012-09-20 | The Procter & Gamble Company | Porous disintegratable solid substrate for personal health care applications |
US20160184230A1 (en) * | 2014-04-30 | 2016-06-30 | Aron H. Blaesi | Melt-processed polymeric cellular dosage form |
WO2019069108A1 (en) * | 2017-10-04 | 2019-04-11 | Debreceni Egyetem | SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME |
DE102020110089A1 (de) * | 2020-04-09 | 2021-10-14 | Karl-Franzens-Universität Graz | Verfahren zum Herstellen eines porösen Wirkstoffträgers mittels Heißschmelzextrusion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612212A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
DE3612211A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
IT1247529B (it) * | 1991-04-24 | 1994-12-17 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
JP2966735B2 (ja) * | 1994-07-29 | 1999-10-25 | 積水化成品工業株式会社 | 熱可塑性樹脂押出機 |
-
1996
- 1996-09-03 DE DE19635676A patent/DE19635676A1/de not_active Withdrawn
-
1997
- 1997-08-21 DK DK97944775T patent/DK0932393T3/da active
- 1997-08-21 ES ES97944775T patent/ES2175469T3/es not_active Expired - Lifetime
- 1997-08-21 AT AT97944775T patent/ATE215362T1/de not_active IP Right Cessation
- 1997-08-21 TR TR1999/00447T patent/TR199900447T2/xx unknown
- 1997-08-21 BR BR9711982A patent/BR9711982A/pt not_active Application Discontinuation
- 1997-08-21 DE DE59706898T patent/DE59706898D1/de not_active Expired - Lifetime
- 1997-08-21 WO PCT/EP1997/004550 patent/WO1998009616A1/de active IP Right Grant
- 1997-08-21 EP EP97944775A patent/EP0932393B1/de not_active Expired - Lifetime
- 1997-08-21 IL IL12843997A patent/IL128439A/xx not_active IP Right Cessation
- 1997-08-21 AU AU46177/97A patent/AU740856B2/en not_active Ceased
- 1997-08-21 RU RU99107556/14A patent/RU2200004C2/ru active
- 1997-08-21 JP JP10512176A patent/JP2000517327A/ja active Pending
- 1997-08-21 PT PT97944775T patent/PT932393E/pt unknown
- 1997-08-21 CZ CZ99676A patent/CZ67699A3/cs unknown
- 1997-08-21 US US09/254,012 patent/US6150424A/en not_active Expired - Lifetime
- 1997-08-21 HU HU9904101A patent/HUP9904101A3/hu unknown
- 1997-08-21 CA CA002264588A patent/CA2264588C/en not_active Expired - Lifetime
- 1997-08-21 CN CN97199572A patent/CN1124129C/zh not_active Expired - Lifetime
- 1997-09-02 ZA ZA977861A patent/ZA977861B/xx unknown
- 1997-09-03 HR HR19635676.8A patent/HRP970472A2/hr not_active Application Discontinuation
-
1999
- 1999-02-26 BG BG103214A patent/BG103214A/xx unknown
- 1999-03-02 NO NO991011A patent/NO991011L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9711982A (pt) | 1999-08-24 |
AU740856B2 (en) | 2001-11-15 |
CA2264588C (en) | 2005-10-18 |
NO991011L (no) | 1999-03-03 |
HUP9904101A3 (en) | 2001-11-28 |
JP2000517327A (ja) | 2000-12-26 |
RU2200004C2 (ru) | 2003-03-10 |
DK0932393T3 (da) | 2002-07-01 |
HUP9904101A2 (hu) | 2000-04-28 |
BG103214A (en) | 1999-09-30 |
US6150424A (en) | 2000-11-21 |
PT932393E (pt) | 2002-09-30 |
ZA977861B (en) | 1999-03-02 |
ATE215362T1 (de) | 2002-04-15 |
CZ67699A3 (cs) | 1999-05-12 |
EP0932393A1 (de) | 1999-08-04 |
CA2264588A1 (en) | 1998-03-12 |
DE19635676A1 (de) | 1998-03-05 |
AU4617797A (en) | 1998-03-26 |
HRP970472A2 (en) | 1998-08-31 |
EP0932393B1 (de) | 2002-04-03 |
CN1124129C (zh) | 2003-10-15 |
CN1237103A (zh) | 1999-12-01 |
WO1998009616A1 (de) | 1998-03-12 |
IL128439A (en) | 2003-02-12 |
TR199900447T2 (xx) | 1999-05-21 |
ES2175469T3 (es) | 2002-11-16 |
IL128439A0 (en) | 2000-01-31 |
DE59706898D1 (de) | 2002-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991011D0 (no) | Fast skumpreparater med aktiv bestandel og fremgangsmÕte for fremstilling derav | |
PT896534E (pt) | Formulacoes para injeccao de avermectinas e milbemicinas a base de oleo de ricino | |
DE60129849D1 (de) | Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe | |
ES2171165T3 (es) | Dispositivo bioerosionable para la administracion de agentes activos. | |
ES2177482T1 (es) | Preparacion mejorada de tebaina y oripavina. | |
MX9802383A (es) | Derivados de pirimidina como antagonistas del receptor 5ht26. | |
DE69721489D1 (de) | Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen | |
IL129054A0 (en) | Benzonaphthyridines as bronchial therapeutics | |
PT1220693E (pt) | Formulacoes para libertacao de proteinas osteogenicas | |
NO951498L (no) | Farmasöytisk preparat for behandling av osteoporose | |
ATE212971T1 (de) | Schmelzbare stabilisatorkombination | |
BR9509975A (pt) | Formulação farmacêutica | |
BR9611320A (pt) | Composição farmacêutica | |
NO914056L (no) | Fremgangsmaate for fremstilling av 5h-benzodiazepinderivat | |
SE9604752D0 (sv) | Formulation and use | |
ZA975638B (en) | New synthetic catechol derivatives, methods of producing them and their use. | |
HRP20000703B1 (en) | Stabile compositions levosimendan and alginic acid | |
AU4136897A (en) | 2,3-dihydrobenzofuran derivative and hepatopathy remedy comprising the same as active ingredient | |
GB0119121D0 (en) | Improvements in and relating to computer systems | |
DE69818988D1 (de) | 9,10-diazatryclo[4.2.11 2,5]decan- und 9,10-diazatricyclo[3.3.1.1 2,6]decanderive mit analgetischer wirkung | |
Hotta | Tsuchiya, K.: Kartini's Image of Java's Landscape | |
DK0833610T3 (da) | Nye afföringsmidler og fremgangsmåde til deres fremstilling | |
Morooka | Sleeping Posture | |
BR7901395U (pt) | Personalização de cadeiras de escritório e método para personalização de cadeiras de escritório |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |